Latest publications — Orchid

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Assessing the association between COVID-19 vaccination and thrombotic thrombocytopenia syndrome (ATTEST Study): Analyses of English data, 2020-2022

Ordóñez-Mena JM. et al, (2026), International Journal of Infectious Diseases, 164

Hepatitis A vaccination coverage in adults with chronic liver disease in primary care in England: a retrospective cohort study

Meza-Torres B. et al, (2025), Lancet Public Health, 10, e647 - e655

A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care population

Forbes AK. et al, (2025), Nephrology Dialysis Transplantation, 40, 71 - 82

Exploring the implementation and integration of structured medication reviews in primary care: A qualitative evaluation using normalization process theory

Reidy C. et al, (2025)

Physical, cognitive, and social triggers of symptom fluctuations in people living with long COVID: an intensive longitudinal cohort study

Greenwood DC. et al, (2024), The Lancet Regional Health - Europe, 46

Phenotype execution and modeling architecture to support disease surveillance and real-world evidence studies: English sentinel network evaluation

Jamie G. et al, (2024), JAMIA Open, 7

AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study

Meeraus W. et al, (2024), Journal of Infection, 88

Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study

Tsang RSM. et al, (2024), Journal of the Royal Society of Medicine, 117, 134 - 148

Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study

Forbes AK. et al, (2024), Eclinicalmedicine, 68

Hepatitis A Vaccination Coverage Among People With Chronic Liver Disease in England (HEALD): Protocol for a Retrospective Cohort Study (Preprint)

Meza-Torres B. et al, (2023)

Sodium-glucose cotransporter-2 inhibitors and kidney outcomes in real-world type 2 diabetes populations: A systematic review and meta-analysis of observational studies

Forbes AK. et al, (2023), Diabetes, Obesity and Metabolism, 25, 2310 - 2330

Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studies

Hinton W. et al, (2023), Diabetes, Obesity and Metabolism, 25, 501 - 515

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study

Tsang RSM. et al, (2023), Eurosurveillance, 28

Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people

Dambha-Miller H. et al, (2023), Family Practice, 40, 330 - 337

Hepatitis A Vaccination Coverage Among People With Chronic Liver Disease in England (HEALD): Protocol for a Retrospective Cohort Study

Meza-Torres B. et al, (2023), JMIR Research Protocols, 12

Load More

1
2
3
4
5

In this section